ArticleProceedings of the National Academy of Sciences of the United States of America2022

Mechanism-based heparanase inhibitors reduce cancer metastasis in vivo.

Casper de Boer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.